Orangecat maintains a narrowly scoped product portfolio centered on its Syntx offering, with observed vulnerabilities clustering around code-injection weaknesses that reflect risks inherent to dynamic code generation and execution mechanisms. Live severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Orangecat over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2026-30305CRITICAL Syntx's command auto-approval module contains a critical OS command injection vulnerability that renders its whitelist security mechanism completely ineffective. The system relies | Mar 30, 2026 | 9.8 | 28 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Orangecat.
Media articles that mention a CVE ID that affects a product developed by Orangecat — matched by CVE ID, not by vendor name.